Author

N. Walton

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Bera· 1 shared A. Dariush· 1 shared A. Küpkü Yoldas· 1 shared B. Bodenmiller· 1 shared C. Gonzalez Fernandez· 1 shared C. M. Mulvey· 1 shared CRUK IMAXT Grand Challenge Team· 1 shared D. Bressan· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Bera

Author profile →

2 papers

Recent·Most cited

Exploration and analysis of molecularly annotated, 3D models of breast cancer at single-cell resolution using virtual reality

D. Bressan, C. M. Mulvey, F. Qosaj, R. Becker, F. Grimaldi, S. Coffey, S. L. Vogl, L. Kuett, R. Catena, A. Dariush, C. Gonzalez Fernandez, E. A. Gonzalez Solares, M. Al Sa'd, A. Küpkü Yoldas, T. Whitmarsh, , G. J. Hannon

The paper introduces Theia, a virtual reality platform for exploring 3D molecularly annotated cancer datasets, and provides breast cancer datasets for analysis.

bioRxiv · Jun 28, 2021 · PreprintCancer Biology

Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration into human lung cells

H. Caohuy, O. Eidelman, T. Chen, Q. Yang, A. Bera, N. Walton, H. B. Pollard

This study shows cardiac medications like ouabain and digitoxin inhibit ACE2 binding to SARS-CoV-2 Spike and block virus entry into human lung cells.

bioRxiv · Jun 2, 2021Pharmacology & Toxicology